Organoid test to guide treatment for bile duct cancer
Treatments studied
Part of Cancer clinical trials.
This trial uses a lab-grown model of your tumor (an organoid) to test which drugs work best before giving them to you. If you cannot have surgery to remove your cancer, this approach may help find a more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have bile duct or gallbladder cancer that cannot be removed by surgery.
- You are in generally good health (able to care for yourself, up and about).
- Your liver and kidney function meet specific lab guidelines.
- You have not had radiation therapy in the past 12 weeks.
- You are willing to use effective birth control during the study and for a period after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a lab model made from your tumor (an “organoid”) to predict how well a cancer medicine may work for intrahepatic cholangiocarcinoma (bile duct cancer in the liver). If you join, your eligibility depends mainly on age and having the right tumor biopsy sample available.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This trial tests a new treatment called BTC-Ag-T, which uses your own immune cells enhanced in the lab to fight advanced biliary tract cancer (cancer of the bile ducts or gallbladder). It's designed for patients whose cancer has spread or cannot be surgically removed and who have already received standard chemotherapy plus immunotherapy.
This trial tests different treatments for advanced bile duct or gallbladder cancer based on individual tumor features. It may help people who have not had prior therapy for their cancer.
This trial uses a lab-grown miniature tumor (called an organoid) from your biopsy to test which drugs might work best for your breast cancer when standard treatments have stopped working. The goal is to find a personalized treatment option that could be more effective for you.
Hear when a new Advanced Biliary Tract Cancer(BTC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.